Iroquois-class homeodomain protein IRX-4, also known as Iroquois homeobox protein 4, is a protein that in humans is encoded by the IRX4 gene.[5][6]
Function
IRX4 is a member of the Iroquois homeobox gene family. Members of this family appear to play multiple roles during pattern formation of vertebrate embryos.[5]
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000113430 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021604 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ a b "Entrez Gene: iroquois homeobox 4".
- ^ Bruneau BG, Bao ZZ, Tanaka M, Schott JJ, Izumo S, Cepko CL, Seidman JG, Seidman CE (January 2000). "Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand". Dev. Biol. 217 (2): 266–77. doi:10.1006/dbio.1999.9548. PMID 10625552.
Further reading
- Lewis MT, Ross S, Strickland PA, et al. (1999). "Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast". Cell Tissue Res. 296 (3): 549–54. doi:10.1007/s004410051316. PMID 10370142. S2CID 37046813.
- Wang GF, Nikovits W, Bao ZZ, Stockdale FE (2001). "Irx4 forms an inhibitory complex with the vitamin D and retinoic X receptors to regulate cardiac chamber-specific slow MyHC3 expression". J. Biol. Chem. 276 (31): 28835–41. doi:10.1074/jbc.M103716200. PMID 11382777.
- Bayrak F, Kömürcü-Bayrak E, Mutlu B, et al. (2008). "Genetic analysis of the Irx4 gene in hypertrophic cardiomyopathy". Turk Kardiyol Dern Ars. 36 (2): 90–5. PMID 18497553.
- Cirulli ET, Kasperavičiūtė D, Attix DK, et al. (2010). "Common genetic variation and performance on standardized cognitive tests". European Journal of Human Genetics. 18 (7): 815–820. doi:10.1038/ejhg.2010.2. PMC 2987367. PMID 20125193.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
---|
(1) Basic domains |
---|
(1.1) Basic leucine zipper (bZIP) | |
---|
(1.2) Basic helix-loop-helix (bHLH) | Group A | |
---|
Group B | |
---|
Group C bHLH-PAS | |
---|
Group D | |
---|
Group E | |
---|
Group F bHLH-COE | |
---|
|
---|
(1.3) bHLH-ZIP | |
---|
(1.4) NF-1 | |
---|
(1.5) RF-X | |
---|
(1.6) Basic helix-span-helix (bHSH) | |
---|
|
|
(2) Zinc finger DNA-binding domains |
---|
(2.1) Nuclear receptor (Cys4) | subfamily 1 | |
---|
subfamily 2 | |
---|
subfamily 3 | |
---|
subfamily 4 | |
---|
subfamily 5 | |
---|
subfamily 6 | |
---|
subfamily 0 | |
---|
|
---|
(2.2) Other Cys4 | |
---|
(2.3) Cys2His2 | |
---|
(2.4) Cys6 | |
---|
(2.5) Alternating composition | |
---|
(2.6) WRKY | |
---|
|
|
|
(4) β-Scaffold factors with minor groove contacts |
---|
|
|
(0) Other transcription factors |
---|
|
|
see also transcription factor/coregulator deficiencies |